中西医结合心血管病电子杂志
中西醫結閤心血管病電子雜誌
중서의결합심혈관병전자잡지
Cardiovascular Disease Journal of Integrated Traditional Chinese and Western Medicine (Electronic)
2014年
12期
27-28
,共2页
厄贝沙坦%左旋氨氯地平%高血压
阨貝沙坦%左鏇氨氯地平%高血壓
액패사탄%좌선안록지평%고혈압
He sand temple%Left-handed amlodipine%High blood pressure
目的：探讨厄贝沙坦与左旋氨氯地平联合对高血压的疗效。方法收集我院2012年1月～2013年12月收治的100例高血压病患者为研究对象，随机分为对照组50例，观察组50例，对照组单用左旋氨氯地平进行治疗，观察组采取左旋氨氯地平和厄贝沙坦联合治疗，对两组患者的疗效进行对比分析。结果两组患者治疗后血压均有下降，观察组血压下降显著优于对照组（P＜0.05），差异有统计学意义。对照组治疗有效率为70.0%，观察组治疗有效率为92.0%，差异有统计学意义（P＜0.05）。结论采取左旋氨氯地平和厄贝沙坦联合治疗高血压效果显著，疗效确切，安全性高，值得临床进一步推广使用。
目的：探討阨貝沙坦與左鏇氨氯地平聯閤對高血壓的療效。方法收集我院2012年1月～2013年12月收治的100例高血壓病患者為研究對象，隨機分為對照組50例，觀察組50例，對照組單用左鏇氨氯地平進行治療，觀察組採取左鏇氨氯地平和阨貝沙坦聯閤治療，對兩組患者的療效進行對比分析。結果兩組患者治療後血壓均有下降，觀察組血壓下降顯著優于對照組（P＜0.05），差異有統計學意義。對照組治療有效率為70.0%，觀察組治療有效率為92.0%，差異有統計學意義（P＜0.05）。結論採取左鏇氨氯地平和阨貝沙坦聯閤治療高血壓效果顯著，療效確切，安全性高，值得臨床進一步推廣使用。
목적：탐토액패사탄여좌선안록지평연합대고혈압적료효。방법수집아원2012년1월～2013년12월수치적100례고혈압병환자위연구대상，수궤분위대조조50례，관찰조50례，대조조단용좌선안록지평진행치료，관찰조채취좌선안록지평화액패사탄연합치료，대량조환자적료효진행대비분석。결과량조환자치료후혈압균유하강，관찰조혈압하강현저우우대조조（P＜0.05），차이유통계학의의。대조조치료유효솔위70.0%，관찰조치료유효솔위92.0%，차이유통계학의의（P＜0.05）。결론채취좌선안록지평화액패사탄연합치료고혈압효과현저，료효학절，안전성고，치득림상진일보추엄사용。
Objective Irbesartan and explore joint levamlodipine treatment of hypertension. MethodsCollected in our hospital from January 2012 to December 2013 were treated 100 cases of hypertensive patients for the study, Were randomly divided into a control group of 50 patients, Observation group 50 cases, Group alone Levamlodipine treatment, Observation group taking irbesartan L amlodipine combination therapy, Two groups of patients for treatment were analyzed.Results Two groups of patients were decreased after treatment, blood pressure, Blood pressure was signiifcantly decreased in the observation group than the control group (P<0.05). The control group was 70.0% effective, Observation group therapy effective rate was 92.0%.(P<0.05) difference was statistically signiifcant.Conclusion Taking L-amlodipine combination therapy of hypertension irbesartan signiifcant effect, Curative effect, High safety, Worthy of further clinical use.
